News
Johnson & Johnson (NYSE:JNJ) has raised its offer to settle thousands of lawsuits alleging its baby powder caused cancer to over $8.2B, people familiar with the matter told Bloomberg, compared to ...
Johnson & Johnson has boosted to more than $8.2 billion its offer to settle thousands of lawsuits by people who say its baby powder gave them cancer, according to people familiar with the matter.
J&J's $8.2 Billion Settlement Linked To Iconic Baby Powder Faces Court Test After months of wrangling, a federal judge in Houston early next year will decide whether J&J's bid to quickly settle ...
J&J has won most of the trials in ovarian cancer cases and it successfully appealed some of its initial losses, with a $2 billion verdict standing as an outlier loss for the company.
Johnson & Johnson is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions alleging its Baby Powder and other talc products ...
J&J faces lawsuits from more than 62,000 claimants who alleged that its baby powder and other talc products were contaminated with asbestos and caused ovarian and other cancers.
Johnson & Johnson (JNJ) has reportedly raised its offer to settle thousands of lawsuits alleging its baby powder caused cancer to over $8.2B.
J&J’s decision to sweeten its settlement offer would bring the total the firm has agreed to pay out – or already expended – to resolve baby powder cases to more than $13.4 billion.
NEW YORK (Reuters) - Johnson & Johnson is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions alleging its Baby Powder and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results